Showing results (31-40 of 250) with videos related to
Sort By:
Pageof 25
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 17, 2021
Complete ADAMTS13 remission in a patient with refractory autoimmune-mediated thrombotic thrombocytopenic purpura after infliximabNatalie Bavli, Nicholas Lee, Ravi Sarode, et al.Journal of Clinical Apheresis|November 8, 2024
Efficacy of a Standardized Regimen of Therapeutic Plasma Exchange and IVIG for Treatment of Antibody-Mediated Rejection in Lung Transplant RecipientsAmelework Wodajo, Ravi Sarode, Nicole De Simone, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 18, 2017
A case of autoimmune severe acquired von Willebrand syndrome (type 3-like)Chakri Gavva, Prapti Patel, Yu-Min Shen, et al.Archives of Surgery (Chicago, Ill. : 1960)|July 23, 2008
A massive transfusion protocol to decrease blood component use and costsTerence O'Keeffe, Majed Refaai, Kathryn Tchorz, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|March 12, 2026
Thrombin Generation in Pediatric Haemophilia A Patients on Extended Half-Life FVIII versus Non-FVIII TherapiesJessica Garcia, Sean G Yates, Ravi Sarode, et al.Transfusion|March 25, 2014
Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case reportSean Yates, Karen Matevosyan, Cynthia Rutherford, et al.Transfusion|November 22, 2015
Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world settingRanjit Joseph, James Burner, Sean Yates, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2016
Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?Sean G Yates, Sabra Smith, William Tharpe, et al.Journal of Clinical Apheresis|July 26, 2011
Advantages of isovolemic hemodilution-red cell exchange therapy to prevent recurrent stroke in sickle cell anemia patientsRavi Sarode, Karén Matevosyan, Zora R Rogers, et al.Journal of Clinical Apheresis|July 13, 2010
Rinseback during red blood cell exchange with COBE Spectra does not affect fraction of cells remaining or post-exchange hematocritRamesh Bhagat, Karén Matevosyan, Rebecca Jones, et al.Pageof 25